Dexcom (DXCM) Gross Margin Growth (5y) (2015 - 2026)
Dexcom (DXCM) Gross Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.60 Bn | 194.00 Bn | 7.27 Bn |
| 2 | Stryker | 127.14 Bn | 123.66 Bn | 4.50 Bn |
| 3 | Medtronic | 118.89 Bn | 109.67 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.11 Bn | 72.57 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.03 Bn | 47.78 Bn | 1.35 Bn |
| 6 | Dexcom | 34.31 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.18 Bn | 18.77 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -665.00 |
| Mar 31, 2026 | -515.00 |
| Dec 31, 2025 | -722.00 |
| Sep 30, 2025 | -748.00 |
| Jun 30, 2025 | -335.00 |
| Mar 31, 2025 | -646.00 |
| Dec 31, 2024 | -794.00 |
| Sep 30, 2024 | -257.00 |
| Jun 30, 2024 | 102.00 |
| Mar 31, 2024 | 83.00 |
| Dec 31, 2023 | -245.00 |
| Sep 30, 2023 | 71.00 |
| Jun 30, 2023 | -63.00 |
| Mar 31, 2023 | -209.00 |
| Dec 31, 2022 | -306.00 |
| Sep 30, 2022 | -458.00 |
| Jun 30, 2022 | -431.00 |
| Mar 31, 2022 | -282.00 |
| Dec 31, 2021 | -48.00 |
| Sep 30, 2021 | 70.00 |